X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (112209) 112209
Magazine Article (360) 360
Book / eBook (191) 191
Conference Proceeding (78) 78
Web Resource (78) 78
Government Document (40) 40
Dissertation (25) 25
Publication (16) 16
Book Chapter (14) 14
Newsletter (12) 12
Book Review (6) 6
Streaming Video (3) 3
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (78367) 78367
female (55708) 55708
animals (50291) 50291
male (47252) 47252
oncology (29190) 29190
middle aged (28147) 28147
adult (22209) 22209
rats (21932) 21932
aged (21902) 21902
mice (21740) 21740
cancer (20540) 20540
antineoplastic agents - adverse effects (9995) 9995
risk factors (9772) 9772
chemotherapy (9191) 9191
neoplasms - drug therapy (8859) 8859
neoplasms, experimental - chemically induced (8470) 8470
neoplasms - chemically induced (8296) 8296
carcinogens (8121) 8121
time factors (7834) 7834
antineoplastic combined chemotherapy protocols - adverse effects (7376) 7376
tumors (7100) 7100
dose-response relationship, drug (6901) 6901
antineoplastic combined chemotherapy protocols - therapeutic use (6747) 6747
breast neoplasms - drug therapy (6533) 6533
treatment outcome (6372) 6372
research (6330) 6330
risk (6229) 6229
pharmacology & pharmacy (5931) 5931
breast cancer (5691) 5691
antineoplastic agents - therapeutic use (5685) 5685
care and treatment (5570) 5570
liver neoplasms - chemically induced (5506) 5506
carcinogens - toxicity (5488) 5488
expression (5407) 5407
health aspects (5308) 5308
carcinogenesis (5298) 5298
toxicology (5279) 5279
cell line, tumor (5258) 5258
aged, 80 and over (5241) 5241
lung neoplasms - chemically induced (5183) 5183
apoptosis (5181) 5181
skin neoplasms - chemically induced (4935) 4935
adolescent (4713) 4713
therapy (4579) 4579
analysis (4222) 4222
medicine & public health (4032) 4032
disease models, animal (4022) 4022
biochemistry & molecular biology (4005) 4005
drug administration schedule (3956) 3956
lung neoplasms - drug therapy (3919) 3919
rats, inbred f344 (3905) 3905
neutropenia - chemically induced (3833) 3833
retrospective studies (3688) 3688
breast-cancer (3680) 3680
pregnancy (3550) 3550
cell biology (3529) 3529
research article (3511) 3511
liver neoplasms, experimental - chemically induced (3501) 3501
child (3479) 3479
risk assessment (3400) 3400
metastasis (3330) 3330
carcinoma (3319) 3319
follow-up studies (3298) 3298
medicine, general & internal (3281) 3281
public, environmental & occupational health (3281) 3281
breast neoplasms - chemically induced (3255) 3255
rats, inbred strains (3245) 3245
mammary neoplasms, experimental - chemically induced (3218) 3218
neoplasm transplantation (3158) 3158
nausea - chemically induced (3131) 3131
occupational diseases - chemically induced (3109) 3109
cells (3070) 3070
adenocarcinoma - chemically induced (3034) 3034
prevention (2995) 2995
prognosis (2994) 2994
toxicity (2960) 2960
antineoplastic agents - administration & dosage (2901) 2901
proteins (2890) 2890
incidence (2879) 2879
gene expression (2863) 2863
mice, inbred c57bl (2840) 2840
hematology (2787) 2787
cricetinae (2765) 2765
breast neoplasms - pathology (2753) 2753
mortality (2731) 2731
mutation (2728) 2728
neoplasm metastasis (2725) 2725
vomiting - chemically induced (2718) 2718
prospective studies (2689) 2689
lung neoplasms - pathology (2674) 2674
liver - drug effects (2673) 2673
urinary bladder neoplasms - chemically induced (2646) 2646
colonic neoplasms - chemically induced (2631) 2631
growth (2590) 2590
immunohistochemistry (2553) 2553
liver neoplasms - pathology (2518) 2518
cisplatin - adverse effects (2516) 2516
rats, sprague-dawley (2504) 2504
9,10-dimethyl-1,2-benzanthracene (2498) 2498
liver (2490) 2490
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (164) 164
Online Resources - Online (83) 83
UofT at Mississauga - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Engineering & Comp. Sci. - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
UTL at Downsview - May be requested (2) 2
UofT at Scarborough - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Gerstein Science - Theses (1) 1
OISE - Stacks (1) 1
Robarts - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (103511) 103511
Japanese (2898) 2898
German (2509) 2509
Russian (1812) 1812
French (1739) 1739
Chinese (820) 820
Italian (570) 570
Spanish (535) 535
Polish (335) 335
Dutch (197) 197
Portuguese (183) 183
Danish (167) 167
Swedish (121) 121
Hungarian (115) 115
Norwegian (114) 114
Czech (96) 96
Finnish (49) 49
Hebrew (33) 33
Romanian (28) 28
Bulgarian (25) 25
Croatian (25) 25
Ukrainian (21) 21
Slovak (17) 17
Serbian (12) 12
Korean (8) 8
Turkish (8) 8
Bosnian (2) 2
Lithuanian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Greek (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 2, pp. 153 - 163
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 2013, Volume 63, Issue 4, pp. 249 - 279
Answer questions and earn CME/CNE Advances in genomics and molecular biology have identified aberrant proteins in cancer cells that are attractive targets for... 
toxicity | kinase inhibitors | therapeutic index | targeted agents | mechanism‐based toxicity | immunotherapeutic agents | off‐target toxicity | mechanism-based toxicity | off-target toxicity | MEK INHIBITOR TRAMETINIB | PULMONARY ARTERIAL-HYPERTENSION | I DOSE-ESCALATION | CHRONIC MYELOID-LEUKEMIA | GROWTH-FACTOR RECEPTOR | ONCOLOGY | PLACEBO-CONTROLLED TRIAL | III CLINICAL-TRIAL | SQUAMOUS-CELL CARCINOMAS | TIVANTINIB ARQ 197 | SIGNAL-REGULATED KINASE | Mood Disorders - chemically induced | Drug Eruptions - etiology | Peripheral Nervous System Diseases - chemically induced | Bone Marrow Diseases - chemically induced | Cachexia - chemically induced | Endocrine System Diseases - chemically induced | Pleural Effusion - chemically induced | Humans | Drug Eruptions - therapy | Immune System Diseases - chemically induced | Lung Diseases, Interstitial - chemically induced | Thrombocytopenia - chemically induced | Diarrhea - chemically induced | Neoplasms - drug therapy | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Hyperbilirubinemia - chemically induced | Venous Thromboembolism - chemically induced | Vision Disorders - chemically induced | Hemorrhage - chemically induced | Heart Diseases - chemically induced | Hyperlipidemias - chemically induced | Magnesium - blood | Antimitotic agents | Drugs | Prevention | Complications and side effects | Drug targeting | Antineoplastic agents | Health aspects | Risk factors | Proteins | Side effects | Genomics | Cytotoxicity | Molecular biology | Cancer therapies | Cells | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Infections - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
The lancet oncology, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 770 - 778
Summary Background Pancreatic cancer statistics are dismal, with a 5-year survival of less than 10%, and more than 50% of patients presenting with metastatic... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | MITOCHONDRIAL METABOLISM | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Sulfides - administration & dosage | Pancreatic Neoplasms - drug therapy | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Hyperglycemia - chemically induced | Leucovorin - adverse effects | Fluorouracil - adverse effects | Hypokalemia - chemically induced | Camptothecin - administration & dosage | Female | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Hematologic Diseases - chemically induced | Sensation Disorders - chemically induced | Abdominal Pain - chemically induced | Pancreatic Neoplasms - pathology | Anemia - chemically induced | Thrombocytopenia - chemically induced | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Hypoalbuminemia - chemically induced | Maximum Tolerated Dose | Sepsis - chemically induced | Sulfides - adverse effects | Aged | Caprylates - administration & dosage | Caprylates - adverse effects | Organoplatinum Compounds - adverse effects | Lymphopenia - chemically induced | Enzymes | Medical colleges | Care and treatment | Metastasis | Antineoplastic agents | Cells | Antimitotic agents | Cancer patients | Chemotherapy | Pancreatic cancer | Physiological aspects | Product development | Cancer
Journal Article
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2017, Volume 146, Issue 2, pp. 386 - 391
Abstract Objectives Women with ovarian cancer can have long overall survival and goals of treatment change over time from cure to remission to stable disease.... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Peripheral Nervous System Diseases - chemically induced | Diarrhea - psychology | Nausea - chemically induced | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Fatigue - chemically induced | Pain - chemically induced | Diarrhea - chemically induced | Arthralgia - chemically induced | Gastroesophageal Reflux - chemically induced | Nausea - psychology | Alopecia - psychology | Young Adult | Constipation - psychology | Patient Care Planning | Sexual Dysfunction, Physiological - psychology | Antineoplastic Agents - adverse effects | Adult | Female | Surveys and Questionnaires | Neoplasm Recurrence, Local - psychology | Survivors - psychology | Gastroesophageal Reflux - psychology | Ovarian Neoplasms - drug therapy | Arthralgia - psychology | Ovarian Neoplasms - psychology | Memory Disorders - psychology | Attitude to Health | Peripheral Nervous System Diseases - psychology | Fatigue - psychology | Sexual Dysfunction, Physiological - chemically induced | Drug-Related Side Effects and Adverse Reactions - etiology | Hospitalization | Remission Induction | Constipation - chemically induced | Vomiting - chemically induced | Pain - psychology | Adolescent | Vomiting - psychology | Quality of Life | Alopecia - chemically induced | Aged | Neoplasm Staging | Drug-Related Side Effects and Adverse Reactions - psychology | Memory Disorders - chemically induced | Complications and side effects | Ovarian cancer | Index Medicus
Journal Article
Journal Article